1. Cordoro KM, Ganz JE: Training room management of medical conditions: Sports dermatology. Clin Sports Med 24(3):565-599, 2005
2. Pecci M, Comeau D, Chawla V: Skin conditions in the athlete. Am J Sports Med 37(2):406-418, 2009
3. Strauss RH et al: Illness and absence among wrestlers, swimmers, and gymnasts at a large university. Am J Sports Med 16:653, 1998
4. Gaulrapp H, Weber A, Rosemeyer B: Injuries in mountain biking. Knee Surg Sports Traumatol Arthroscopy 9:48-53, 2001
5. Heitkamp HC, Horstmann T, Schalinski H: In-line skating: Injuries and prevention. J Sports Med Physical Fitness 40:247-253, 2000
6. Brenner IK et al: Infection in athletes. Sports Med 17:86, 1944
7. Perz-Perdomo R et al: Description of morbidity notified in the epidemiologic surveillance system of the XVII Central American and Carribbean Sport Games, Puerto Rico, 1993. Puerto Rico Health Sci J 13:267, 1993
8. Shephard RJ: Science and medicine of canoeing and kayaking. Sports Med 4:19, 1997
9. Englund SL, Adams BB: Winter sports dermatology: A review. Cutis 83(1):42-48, 2009
10. Redziniak DE et al: Methicillin-resistant Staphylococcus aureus (MRSA) in the Athlete. Int J Sports Med 30(8):557-562, 2009
11. Many PS; Preventing community-associated methicillin-resistant Staphylococcus aureus among student athletes. J Sch Nurs 24(6):370-378, 2008
12. Stevens MP et al; Community-acquired methicillin resistant Staphylococcus aureus in a women's collegiate basketball team. South Med J 101(10):1067-1068, 2008
13. Bowers AL, Huffman GR, Sennett BJ: Methicillin-resistant Staphylococcus aureus infections in collegiate football players. Med Sci Sports Exerc 40(8):1362-1367, 2008
14. Cohen PR: Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. South Med J 99(6):596-602, 2005 (Print version)
15. Arnold FW, Wojda B: An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus. J Ky Med Assoc May;103(5):206-210, 2005
16. Centers for Disease Control and Prevention (CDC): Methicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Aug 22;52(33):793-795, 2003 (Print version)
17. Nguyen DM, Mascola L, Brancoft E: Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis Apr;11(4):526-532, 2005
18. Begier EM et al: Connecticut Bioterrorism Field Epidemiology Response Team. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis Nov 15;39(10):1446-1453, 2004
19. Kazakova SV et al: A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med Feb 3;352(5):468-475, 2005 (Print version)
20. Wang J et al: An outbreak of Methicillin-resistant Staphylococcus aureus cutaneous infection in a saturation diving facility. Undersea Hyperb Med Winter;30(4):277-284, 2003
21. Calfee DP et al: Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infect Control Hosp Epidemiol Jun;24(6):422-426, 2003
22. Ellis MW et al: Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis Oct 1;39(7):971-979, 2004
23. Centers for Disease Control and Prevention (CDC): Methicillin-resistant Staphylococcus aureus among players on a high school football team—New York City, 2007. MMWR Mortal Jan 30;58(3):52-55, 2009
24. Fridkin SK et al: Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med Apr 7;352(14):1436-1444, 2005 (Print version)
25. Young DM et al: Perdreau-Remington F, Lee C, Mankani M, Mackersie R, Schecter WP. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg Sep;139(9):947-951, 2004
26. Lee MC et al: Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J Feb;23(2):123-127, 2004
27. Rutar T et al: Bilateral Blindness From Orbital Cellulitis Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus. Am J Ophthalmol Oct;140(4):740-742, 2005
28. Takizawa Y et al: A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol 2005 Jul;43(7):3356-3363, 2005
29. Boyle-Vavra S et al: Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J Clin Microbiol Sep;43(9):4719-4730, 2005
30. Braun L et al: Increasing
clindamycin resistance among methicillin-resistant
Staphylococcus aureus in 57 northeast United States military treatment facilities.
Pediatr Infect Dis J Jul;
24(7):622-626, 2005
31. Kaplan SL et al: Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis Jun 15;40(12):1785-1791, 2005
32. Lewis JS 2nd, Jorgensen JH: Inducible
clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?
Clin Infect Dis 2005 Jan 15;
40(2):280-285.
33. Frank AL et al:
Clindamycin treatment of methicillin-resistant
Staphylococcus aureus infections in children.
Pediatr Infect Dis J;
21:530-534, 2002
34. Siberry GK et al: Failure of
clindamycin treatment of methicillin-resistant
Staphylococcus aureus expressing inducible
clindamycin resistance in vitro.
Clin Infect Dis 37:1257-1260, 2003
35. Lewis JS 2nd, Jorgensen JH: Inducible
clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned?
Clin Infect Dis 40:280-285, 2005
36. Sattler CA, Mason EO Jr, Kaplan SL: Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 21:910-917, 2002
37. Martinez-Aguilar G et al:
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible
Staphylococcus aureus in children.
Pediatr Infect Dis J 22:593-598, 2003
38. Levin TP et al: Potential
clindamycin resistance in clindamycin-susceptible, erythromycin-resistant
Staphylococcus aureus: report of a clinical failure.
Antimicrobial Agents Chemother 49:1222-1224, 2005
39. Wang CC et al: Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis Aug 15;39(4):481-487, 2004
40. Weigelt J et al:
Linezolid versus
vancomycin in treatment of complicated skin and soft tissue infections.
Antimicrob Agents Chemother Jun;
49(6):2260-2266, 2005
41. Sharpe JN, Shively EH, Polk HC Jr: Clinical and economic outcomes of oral
linezolid versus intravenous
vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant
Staphylococcus aureus.
Am J Surg Apr;
189(4):425-428, 2005 (Print version)
42. Li JZ et al: Effect of
linezolid versus
vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
Surg Infect (Larchmt) Spring;
4(1):57-70, 2003
43. Mangili A et al: Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis Apr 1;40(7):1058-1060, 2005
44. Hayden MK et al: Development of
Daptomycin resistance in vivo in methicillin-resistant
Staphylococcus aureus.
J Clin Microbiol Oct;
43(10):5285-5287, 2005
45. Vaudaux P et al: Intensive therapy with
ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant
Staphylococcus aureus.
Antimicrob Agents Chemother Sep;
49(9):3789-3793, 2005
46. Miller M et al: Staphylococcus aureus in the community: colonization versus infection. PLoS One Aug 20;4(8):e6708, 2009
47. Garza D et al: Ineffectiveness of surveillance to control community-acquired methicillin-resistant Staphylococcus aureus in a professional football team. Clin J Sport Med Nov;19(6):499-501, 2009
48. Sanders JC: Reducing MRSA infections in college student athletes: implementation of a prevention program. J Community Health Nurs Oct;26(4):161-172, 2009
49. Elston DM: Handling a community-acquired methicillin-resistant Staphylococcus aureus outbreak: emerging data. Cutis Aug;82(2 Suppl 2):13-17, 2008
50. Block C et al: Evaluation of chlorhexidine and povidone
iodine activity against methicillin-resistant
Staphylococcus aureus and vancomycin-resistant
Enterococcus faecalis using a surface test.
J Hosp Infect Oct;
46(2):147-152, 2000
51. Zhang YH et al: Study on the resistance of methicillin-resistant Staphylococcus aureus to iodophor and chlorhexidine. Zhonghua Liu Xing Bing Xue Za Zhi Mar;25(3):248-250, 2004
52. Kampf G, Jarosch R, Ruden H: Limited effectiveness of chlorhexidine based hand disinfectants against methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect Apr;38(4):297-303, 1999
53. Suzuki J et al: In vitro susceptibility of Staphylococcus aureus including MRSA to four disinfectants. ASDC J Dent Child Jul-Aug;64(4):260-263, 1997
54. Brenwald NP, Fraise AP: Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect Oct;55(2):141-144, 2003
55. Bamber AI, Neal TJ: An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. J Hosp Infect Feb;41(2):107-109, 1999
56. Mulvey MR et al: Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis Jun;11(6):844-850, 2005
57. Harbarth S et al: Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of
mupirocin for eradicating carriage of methicillin-resistant
Staphylococcus aureus.
Antimicrob Agents Chemother Jun;
43(6):1412-1416, 1999
58. Pickup TL, Adams BB: Prevalence of tinea pedis in professional and college soccer players versus non-athletes. Clin J Sport Med Jan;17(1):52-54, 2007
59. Derya A, Ilgen E, Metin E: Characteristics of sports-related dermatoses for different types of sports: a cross-sectional study. J Dermatol Aug;32(8):620-625, 2005
60. Shiraki Y et al: A nationwide survey of Trichophyton tonsurans infection among combat sport club members in Japan using a questionnaire form and the hairbrush method. J Am Acad Dermatol 2006 Apr;54(4):622-626, 2005
61. Ergin S et al: An experience from an outbreak of tinea capitis gladiatorum due to Trichophyton tonsurans. Clin Exp Dermatol Mar;31(2):212-214, 2006
62. Fujihiro M: [The part of a hospital dermatologist. Prevention of Trichophyton tonsurans infection]. Nippon Ishinkin Gakkai Zasshi 49(3):191-195, 2008
63. Shiraki Y et al: Commonly affected body sites in 92 Japanese combat sports participants with Trichophyton tonsurans infection. Mycoses 52(4):339-342, 2009; Sep 12, 2008 [Epub ahead of print] PMID: 18793263
64. Shiraki Y et al: Assessment of the treatment protocol described in the guidelines for Trichophyton tonsurans infection. Nippon Ishinkin Gakkai Zasshi 49(1):27-31, 2008
65. Shinoda H, Nishimoto K: [Clinical study of 57 cases of infection with Trichophyton tonsurans examined at a dermatology clinic in Saga Prefecture, Japan]. Nippon Ishinkin Gakkai Zasshi 48(2):79-84, 2007
66. Mochizuki T et al: Epidemiology of sporadic (non-epidemic) cases of Trichophyton tonsurans infection in Japan based on PCR-RFLP analysis of non-transcribed spacer region of ribosomal RNA gene. Jpn J Infect Dis May;61(3):219-22, 2008
67. Brickman K et al:
Fluconazole as a prophylactic measure for tinea gladiatorum in high school wrestlers.
Clin J Sport Med Sep;
19(5):412-414, 2009
68. Kvernmo HD, et al: Enhanced endothelium-dependent vasodilatation in human skin vasculature induced by physical conditioning. Eur J Applied Physiol Occ Physiol 79:30-36, 1999
69. Lindinger MI: Exercise in the heat: thermoregulatory limitations to performance in humans and horses. Canadian J Applied Physiol 24:152-163, 1999
70. Kato M et al: Thermophysiological effects of two different types of clothing under warm temperatures. Applied Hum Sci 14:119, 1995
71. Bassett DR, et al: Thermoreulatory responses to skin wetting during prolonged treadmill running. Med Sci Sports Exercise 19:28-32, 1997
72. Webster J et al: A light-weight cooling vest enhances performance of athletes in the heat. Ergonomics 2005 Jun 10;48(7):821-837.
73. Arngrimsson SA et al: Cooling vest worn during active warm-up improves 5-km run performance in the heat. J Appl Physiol May;96(5):1867-1874, 2004
74. Fallon KE, May JJ: Harlequin syndrome in two athletes. Br J Sports Med Jan;39(1):e1, 2005
75. Fisher AA: Sports-related cutaneous reactions: Part 1. Dermatoses due to physical agents. Cutis 63:134-136, 1999
76. Kirkland R, Adams BB: Dermatological problems in the football player. Int J Dermatol Aug;45(8):927-932, 2006
77. Mailler-Savage EA, Adams BB: Skin manifestations of running. J Am Acad Dermatol 2006 Aug;55(2):290-301, 2006
78. Inui S, Itami S: 2 cases of sumo wrestlers' friction dermatitis. Contact Dermatitis Jun;58(6):374-375, 2008
79. Ambros-Rudolph CM et al: Malignant melanoma in marathon runners. Arch Dermatol Nov;142(11):1471-1474, 2006
80. Ezzedine K et al: Expatriates in high-UV index and tropical countries: sun exposure and protection behavior in 9,416 French adults. J Travel Med Mar-Apr;14(2):85-91, 2007
81. Richtig E et al: Melanoma markers in marathon runners: increase with sun exposure and physical strain. Dermatology 217(1):38-44, 2008
82. Moehrle M: Outdoor sports and skin cancer. Clin Dermatol Jan–Feb;26(1):12-15, 2008
83. Kockentiet B, Adams BB: Contact dermatitis in athletes. J Am Acad Dermatol Jun;56(6):1048-1055, 2007
84. Amado A, Taylor JS: Contact dermatitis in the bowling pro shop. Dermatitis Nov–Dec;19(6):334-338, 2008
85. Isaksson M, Möller H, Pontén A: Occupational allergic contact dermatitis from epoxy resin in a golf club repairman. Dermatitis Sep–Oct;19(5):E30-32, 2008
86. Kalavala M et al: Allergic contact dermatitis to peppermint foot spray. Contact Dermatitis Jul;57(1):57-58, 2007
87. Martellotta D et al: Contact allergy to p-tert-butylphenol formaldehyde resin and zinc diethyldithiocarbamate in a wet suit. Dermatitis Mar–Apr;19(2):E3-4, 2008
88. Meinke M et al: Migration and penetration of a fluorescent textile dye into the skin—in vivo versus in vitro methods. Exp Dermatol Sep;18(9):789-792, 2009
89. Weston WL, Morelli JG: Dermatitis under soccer shin guards: allergy or contact irritant reaction? Pediatr Dermatol Jan–Feb;23(1):19-20, 2006
90. Bodekaer M et al: Sun protection factor persistence during a day with physical activity and bathing. Photodermatol Photoimmunol Photomed, Dec;24(6):296-300, 2008
91. Fraser SJ et al: Cercarial dermatitis in the UK. Clin Exp Dermatol Apr;34(3):344-346, 2009
92. Walker J, Adams B: Cutaneous manifestations of anabolic-androgenic steroid use in athletes. Int J Dermatol Oct;48(10):1044-1048, 2009
93. Melnik B, Jansen T, Grabbe S: Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges Feb;5(2):110-117, 2007
94. Melnik BC: Androgen abuse in the community. Curr Opin Endocrinol Diabetes Obes Jun;16(3):218-223, 2009.
95. Lindberg-Larsen R, Fogh K: Traumatic pyoderma gangrenosum of the face: pathergy development after bike accident. Dermatology 218(3):272-274, 2009
96. Parkkinen MU et al: Sweating response to moderate thermal stress in atopic dermatitis. Br J Dermatol 126:346, 1992
97. Salzer B et al: Gruppensport als adjuvante Therapie fur Patienten mit atopischem Ekzem. Hautarzt 45:751, 1994
98. Heyer GR, Hornstein OP: Recent studies of cutaneous nociception in atopic and nonatopic subjects. J Dermatol 26:77-86, 1999
99. Stitik TP et al: Greater trochanter enthesopathy: an example of “short course retinoid enthesopathy”: a case report. Am J Physical Med Rehab 78:571, 1999